Table of Contents Table of Contents
Previous Page  378 / 453 Next Page
Information
Show Menu
Previous Page 378 / 453 Next Page
Page Background

Page

16

of

76

All samples were confirmed according to the appropriate reference methods specified for

the matrix and analyte:

(a)

USDA/FSIS-MLG 5.09: Detection, Isolation and Identification of

Escherichia coli

O157:H7 from Meat Products and Carcass and Environmental Sponges

(b)

USDA/FSIS-MLG 5B.05: Detection and Isolation of non-O157 Shiga Toxin-

Producing

Escherichia coli

(STEC) from Meat Products and Carcass and

Environmental Sponges

(c)

FDA/BAM Chapter 4A: Diarrheagenic

Escherichia coli

Independent Validation Study

In accordance with an AOAC-RI Performance Tested Method program approved study

design, the method developer study was conducted by an Independent laboratory, Q

Laboratories, Inc., in Cincinnati, Ohio.

The study was conducted according to the procedures outlined in the AOAC Research

Institute Performance Tested Methods

SM

protocol:

Independent Laboratory Study for the

mericon

E. coli

O157 Screen Plus and mericon

E. coli

STEC O-Type

Pathogen Detection

Assay

(February 2015, Version 1) [7]

.

The

mericon

E. coli

O157 Screen Plus

and

mericon

E.

coli

STEC O-Type

Pathogen Detection Assay

were compared to the following reference

methods: FDA/BAM Chapter 4A for fresh spinach,USDA/FSIS-MLG 5.09 for raw ground

beef (70% lean), and to the USDA/FSIS-MLG 5B.05 for fresh raw beef trim. The study

outline consisted of inclusivity, exclusivity, method comparison, and robustness

evaluations. The inclusivity, exclusivity and robustness evaluations were conducted using

the manual

mericon

DNA extraction procedure. The method comparison study used both

the manual and automated

QIAsymphony

DNA extraction procedures. All data were

analyzed using the Rotor-Gene Q series software.

Inclusivity and Exclusivity

For the inclusivity evaluation of the

mericon

E.coli O157Screen Plus and

mericon

E.coliSTEC O-Type

Pathogen Detection Assay

, 50 pathogenic

E.coli

strains

(including the serovars: O157, O26, O45, O103, O111, and O145)were cultured in mTSB +

CAA for 8-10 hours at 42 ± 1°C and then diluted to 100x the Limit of Detection (LOD =1 x

10

3

).

For the exclusivity portion of the validation, 30 species/strains (including non-pathogenic

E.coli

and non-regulated STEC serovars) closely related to STECs were grown in Brain

Heart Infusion (BHI) broth for 22 ± 2 hours at 37 ± 2ºC.

Inclusivity and exclusivity cultures were randomized, blind-coded and then analyzed with

the appropriate

mericon

assay using the manual

mericon

DNA extraction procedure.

Matrix Study

OMAMAN-36 E/ AOAC PTM Report

ERP Use Only

January 2017

AOAC Research Institute

Expert Review Panel Use Only